Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Mykldee who wrote (3161)	5/20/1998 1:03:00 PM
From: barbara sperino	Read Replies (1) \| Respond to of 25711

HYALF- Here is the news techstocks.com

To: Mykldee who wrote (3161)	5/20/1998 2:27:00 PM
From: Leman	Respond to of 25711

This approval is important and timely, closely following Canada's Sun Awareness Week, May 11 - 17. The medical community and general public are becoming increasingly aware of the dangers of excessive sun exposure. Dr. Jason Rivers, former National Director of the Canadian Dermatology Association's Sun Awareness Program, speaking from the University of British Columbia, stated ''I expect that Solarase will be a very useful addition in the treatment of actinic keratosis. It will help patients reduce the often painful and cosmetically distressing side effects of other therapies.''